Multi-center, randomized, double-blind, placebo-controlled study of two dosages of AM3301 for add-on treatment of mild to moderate active ulcerative colitis
开始日期2010-06-01
申办/合作机构-
EUCTR2004-000684-10-AT
/ Not yet recruitingN/A
A randomised, double-blind, placebo-controlled crossover study to investigate the efficacy and safety of three doses of ME3301 in patients with seasonal allergic rhinitis during allergen challenge in the Vienna Challenge Chamber